Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) reached a new 52-week low during trading on Saturday . The stock traded as low as €16.30 and last traded at €17.22, with a volume of 2619700 shares trading hands. The stock had previously closed at €19.16.
Wall Street Analyst Weigh In
STVN has been the subject of a number of research reports. Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a research report on Monday, December 29th. Morgan Stanley began coverage on Stevanato Group in a report on Monday, December 1st. They issued an “equal weight” rating and a $24.00 price objective for the company. Finally, Wall Street Zen raised Stevanato Group from a “hold” rating to a “buy” rating in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy”.
Get Our Latest Report on Stevanato Group
Stevanato Group Stock Down 10.1%
Hedge Funds Weigh In On Stevanato Group
A number of hedge funds have recently bought and sold shares of the business. Farther Finance Advisors LLC acquired a new stake in Stevanato Group in the third quarter valued at approximately $44,000. First Horizon Corp purchased a new position in shares of Stevanato Group during the 3rd quarter valued at approximately $50,000. State of Wyoming grew its stake in Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after acquiring an additional 2,353 shares during the period. Quantbot Technologies LP purchased a new stake in Stevanato Group in the 3rd quarter worth $68,000. Finally, Van Berkom & Associates Inc. increased its holdings in Stevanato Group by 50.6% in the 3rd quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after acquiring an additional 1,215 shares in the last quarter.
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Featured Stories
- Five stocks we like better than Stevanato Group
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Buy This Stock at 9:30 AM on MONDAY!
- A U.S. “birthright” claim worth trillions – activated quietly
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
